Pharma Equity Group A/S
CSE:PEG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Akiba Holdings Co Ltd
TSE:6840
|
JP |
|
K
|
Kemira Oyj
XBER:KEM
|
FI |
|
Toast Inc
NYSE:TOST
|
US |
|
Rigaku Holdings Corp
TSE:268A
|
JP |
|
Top KingWin Ltd
NASDAQ:WAI
|
CN |
|
O
|
Osisko Development Corp
NYSE:ODV
|
CA |
|
Ninestar Corp
SZSE:002180
|
CN |
|
S
|
Sunil Industries Ltd
BSE:521232
|
IN |
|
METISA Metalurgica Timboense SA
BOVESPA:MTSA4
|
BR |
|
V
|
Visa Steel Ltd
NSE:VISASTEEL
|
IN |
|
Usha Martin Education And Solutions Ltd
NSE:UMESLTD
|
IN |
|
D
|
Delta Israel Brands Ltd
TASE:DLTI
|
IL |
|
A
|
Agricola Nacional SAC e I
SGO:ANASAC
|
CL |
|
I
|
ICP Israel Citrus Plantations Ltd
TASE:CTPL1
|
IL |
Pharma Equity Group A/S
Total Equity
Pharma Equity Group A/S
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pharma Equity Group A/S
CSE:PEG
|
Total Equity
kr25.5m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-12%
|
|
|
Jeudan A/S
CSE:JDAN
|
Total Equity
kr13.1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
10%
|
|
|
Copenhagen Capital A/S
CSE:CPHCAP ST
|
Total Equity
kr582.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
P
|
Prime Office A/S
CSE:PRIMOF
|
Total Equity
kr1.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
15%
|
|
|
Fast Ejendom Danmark A/S
CSE:FED
|
Total Equity
kr791.4m
|
CAGR 3-Years
10%
|
CAGR 5-Years
14%
|
CAGR 10-Years
12%
|
|
|
E
|
EgnsINVEST Ejendomme Tyskland A/S
CSE:EGNETY
|
Total Equity
kr622.3m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
0%
|
CAGR 10-Years
7%
|
|
Pharma Equity Group A/S
Glance View
Pharma Equity Group A/S is a property company, which engages in the investment on real estates. The firm's purpose is, without geographical limitation, to be a holding company for companies with life science activities and to invest in shares admitted to trading on a regulated market place or multilateral trading facility and unlisted capital shares as determined by the board of directors in order to achieve long-term value growth while observing appropriate risk diversification as well as other related businesses.
See Also
What is Pharma Equity Group A/S's Total Equity?
Total Equity
25.5m
DKK
Based on the financial report for Dec 31, 2025, Pharma Equity Group A/S's Total Equity amounts to 25.5m DKK.
What is Pharma Equity Group A/S's Total Equity growth rate?
Total Equity CAGR 10Y
-12%
Over the last year, the Total Equity growth was -22%. The average annual Total Equity growth rates for Pharma Equity Group A/S have been -18% over the past three years , -6% over the past five years , and -12% over the past ten years .
